Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

Giannaccare, Giuseppe; Buzzi, Marina; Versura, Piera

Giannaccare, Giuseppe; Buzzi, Marina; Versura, Piera.

Giannaccare G; Department of Ophthalmology, "Magna Graecia" University, Catanzaro, Italy.
Buzzi M; Emilia Romagna Cord Blood Bank Transfusion Service, "S. Orsola-Malpighi" Teaching Hospital, Bologna, Italy.
Versura P; Ophthalmology Unit, "S. Orsola-Malpighi" Teaching Hospital, University of Bologna, Bologna, Italy.

Blood Transfus ; 18(3): 233-234, 2020 05.

Article in English | MEDLINE | ID: covidwho-385629

Subject(s)

Severe acute respiratory syndrome-related coronavirus; Transfusion Medicine; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Italy; Ophthalmic Solutions; Pandemics; Pneumonia, Viral; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe acute respiratory syndrome-related coronavirus / Transfusion Medicine Limits: Humans Country/Region as subject: Europa Language: English Journal: Blood Transfus Year: 2020 Document Type: Article Affiliation country: 2020.0090-20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google